Spruce Biosciences (SPRB) Common Equity (2019 - 2026)
Spruce Biosciences (SPRB) posted Common Equity of $83.73 million for Q2 2026, up 535.3% from $13.18 million a year earlier and up 141.7% from the prior quarter.
Powered by 
Analysis
Spruce Biosciences (SPRB) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Spruce Biosciences' Common Equity came in at $42.52 million, up 47.5% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -22.2% (FY2020 to FY2025).
- In prior years, Spruce Biosciences' Common Equity was $28.82 million in FY2024 (-62.3%), $76.51 million in FY2023 (+11.7%), $68.49 million in FY2022 (-38.5%) and $111.37 million in FY2021 (-25.5%).
- The Q2 2026 figure stands as the highest quarterly Common Equity since Q3 2023.
- On a year-over-year basis, Common Equity has increased in each of the last three quarters, with growth averaging 45.3% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 535.3%; the weakest was Q3 2025, with a decline of 89.6%.
- According to Business Quant data, Common Equity for the three prior quarters was $34.65 million (Q1 2026), $42.52 million (Q4 2025) and $5.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Spruce Biosciences | 130.79 Mn | 130.79 Mn | - | 83.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.73 Mn |
| Mar 31, 2026 | 34.65 Mn |
| Dec 31, 2025 | 42.52 Mn |
| Sep 30, 2025 | 5.39 Mn |
| Jun 30, 2025 | 13.18 Mn |
| Mar 31, 2025 | 15.32 Mn |
| Dec 31, 2024 | 28.82 Mn |
| Sep 30, 2024 | 51.64 Mn |
| Jun 30, 2024 | 59.17 Mn |
| Mar 31, 2024 | 66.62 Mn |
| Dec 31, 2023 | 76.51 Mn |
| Sep 30, 2023 | 85.38 Mn |
| Jun 30, 2023 | 96.56 Mn |
| Mar 31, 2023 | 108.00 Mn |
| Dec 31, 2022 | 68.49 Mn |
| Sep 30, 2022 | 78.48 Mn |
| Jun 30, 2022 | 89.12 Mn |
| Mar 31, 2022 | 100.24 Mn |
| Dec 31, 2021 | 111.37 Mn |
| Sep 30, 2021 | 119.72 Mn |
API Access
Spruce Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SPRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SPRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SPRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();